
|Videos|October 10, 2021
HAWK study: Higher order OCT analysis for inflammatory signal biomarkers
Justis P. Ehlers, MD, speaks on the findings from a higher-order OCT analysis for inflammatory signal biomarkers in the HAWK Study.
Advertisement
Justis P. Ehlers, MD, The Norman C. and Donna L. Harbert Endowed Chair for Ophthalmic Research, Cole Eye Institute, Cleveland, Ohio, speaks with Ophthalmology Times®' Sheryl Stevenson on the findings from a higher-order OCT analysis for inflammatory signal biomarkers in the HAWK Study.
Are there predictive factors that clinicians can identify in patients who may be more at risk for developing inflammation so that they can mitigate risk?
Learn what this research may mean for clinicians and their patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
2
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis
3
NCX 470 gains positive regulatory feedback in China ahead of US NDA submission
4
Label Updates and Dosing Flexibility in Retinal Vascular Diseases
5























